173 related articles for article (PubMed ID: 19387694)
1. Oral mucositis in patients receiving reduced-intensity regimens for allogeneic hematopoietic cell transplantation: comparison with conventional regimen.
Takahashi K; Soga Y; Murayama Y; Udagawa M; Nishimoto H; Sugiura Y; Maeda Y; Tanimoto M; Takashiba S
Support Care Cancer; 2010 Jan; 18(1):115-9. PubMed ID: 19387694
[TBL] [Abstract][Full Text] [Related]
2. A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens.
Kashiwazaki H; Matsushita T; Sugita J; Shigematsu A; Kasashi K; Yamazaki Y; Kanehira T; Kondo T; Endo T; Tanaka J; Hashino S; Nishio M; Imamura M; Kitagawa Y; Inoue N
Support Care Cancer; 2012 May; 20(5):933-9. PubMed ID: 21494780
[TBL] [Abstract][Full Text] [Related]
3. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
Chaudhry HM; Bruce AJ; Wolf RC; Litzow MR; Hogan WJ; Patnaik MS; Kremers WK; Phillips GL; Hashmi SK
Biol Blood Marrow Transplant; 2016 Apr; 22(4):605-616. PubMed ID: 26409924
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of factors influencing oral mucositis in allogeneic hematopoietic stem cell transplantation.
Ohbayashi Y; Imataki O; Ohnishi H; Iwasaki A; Ogawa T; Inagaki N; Shigeta H; Ohue Y; Tasaka T; Kitanaka A; Kubota Y; Tanaka T; Ishida T; Miyake M
Ann Hematol; 2008 Oct; 87(10):837-45. PubMed ID: 18553082
[TBL] [Abstract][Full Text] [Related]
5. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia.
Robien K; Schubert MM; Bruemmer B; Lloid ME; Potter JD; Ulrich CM
J Clin Oncol; 2004 Apr; 22(7):1268-75. PubMed ID: 15051775
[TBL] [Abstract][Full Text] [Related]
6. Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimen.
Maruyama D; Fukuda T; Kato R; Yamasaki S; Usui E; Morita-Hoshi Y; Kim SW; Mori S; Heike Y; Makimoto A; Tajima K; Tanosaki R; Tobinai K; Takaue Y
Biol Blood Marrow Transplant; 2007 Aug; 13(8):932-41. PubMed ID: 17640597
[TBL] [Abstract][Full Text] [Related]
7. Progress of oral care and reduction of oral mucositis--a pilot study in a hematopoietic stem cell transplantation ward.
Soga Y; Sugiura Y; Takahashi K; Nishimoto H; Maeda Y; Tanimoto M; Takashiba S
Support Care Cancer; 2010 Feb; 19(2):303-7. PubMed ID: 20842384
[TBL] [Abstract][Full Text] [Related]
8. Oral mucositis in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation in relation to the conditioning used prior to transplantation.
Wysocka-Słowik A; Gil L; Ślebioda Z; Kręgielczak A; Dorocka-Bobkowska B
Ann Hematol; 2021 Aug; 100(8):2079-2086. PubMed ID: 34117519
[TBL] [Abstract][Full Text] [Related]
9. Oral cryotherapy for oral mucositis management in patients receiving allogeneic hematopoietic stem cell transplantation: a prospective randomized study.
Lu Y; Zhu X; Ma Q; Wang J; Jiang P; Teng S; Zhou L; Wu D; Wang H
Support Care Cancer; 2020 Apr; 28(4):1747-1754. PubMed ID: 31302767
[TBL] [Abstract][Full Text] [Related]
10. Severity of oral mucositis in patients undergoing hematopoietic cell transplantation and an oral laser phototherapy protocol: a survey of 30 patients.
Eduardo FP; Bezinelli L; Luiz AC; Correa L; Vogel C; Eduardo CP
Photomed Laser Surg; 2009 Feb; 27(1):137-44. PubMed ID: 18699729
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics of Children and Adolescents Undergoing Hematopoietic Cell Transplantation Who Develop Oral Mucositis.
Donohoe C; Bosi JK; Sykes A; Lu Z; Mandrell B
Oncol Nurs Forum; 2018 Jul; 45(4):457-462. PubMed ID: 29947353
[TBL] [Abstract][Full Text] [Related]
12. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
Cutler C; Li S; Kim HT; Laglenne P; Szeto KC; Hoffmeister L; Harrison MJ; Ho V; Alyea E; Lee SJ; Soiffer R; Sonis S; Antin JH
Biol Blood Marrow Transplant; 2005 May; 11(5):383-8. PubMed ID: 15846292
[TBL] [Abstract][Full Text] [Related]
13. Oral mucositis-related oropharyngeal pain and correlative tumor necrosis factor-alpha expression in adult oncology patients undergoing hematopoietic stem cell transplantation.
Fall-Dickson JM; Ramsay ES; Castro K; Woltz P; Sportés C
Clin Ther; 2007; 29 Suppl():2547-61. PubMed ID: 18164921
[TBL] [Abstract][Full Text] [Related]
14. Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation.
Treister N; Nieder M; Baggott C; Olson E; Chen L; Dang H; Krailo M; August A; Sung L
Br J Cancer; 2017 Jan; 116(1):21-27. PubMed ID: 27875526
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of mouth rinse in preventing oral mucositis in patients receiving high-dose cytarabine for allogeneic hematopoietic stem cell transplantation.
Mori T; Hasegawa K; Okabe A; Tsujimura N; Kawata Y; Yashima T; Kobayashi N; Kondo S; Aisa Y; Kato J; Tsunoda K; Nagai T; Nakagawa T; Shigematsu N; Kubo A; Ikeda Y; Okamoto S
Int J Hematol; 2008 Dec; 88(5):583-587. PubMed ID: 18972188
[TBL] [Abstract][Full Text] [Related]
16. Cost and effectiveness of reduced-intensity and conventional allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome.
Imataki O; Kamioka T; Fukuda T; Tanosaki R; Takaue Y
Support Care Cancer; 2010 Dec; 18(12):1565-9. PubMed ID: 20967555
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD.
Sugita J; Matsushita T; Kashiwazaki H; Kosugi M; Takahashi S; Wakasa K; Shiratori S; Ibata M; Shono Y; Shigematsu A; Obara M; Fujimoto K; Endo T; Nishio M; Kondo T; Hashino S; Tanaka J; Asaka M; Imamura M
Bone Marrow Transplant; 2012 Feb; 47(2):258-64. PubMed ID: 21423118
[TBL] [Abstract][Full Text] [Related]
18. Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: serial comparison with conventional myeloablative transplantation.
Saito T; Kanda Y; Nakai K; Kim SW; Arima F; Kami M; Tanosaki R; Tobinai K; Wakasugi H; Heike Y; Mineishi S; Takaue Y
Bone Marrow Transplant; 2003 Sep; 32(6):601-8. PubMed ID: 12953133
[TBL] [Abstract][Full Text] [Related]
19. Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis.
Epstein JB; Hancock PJ; Nantel S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Aug; 96(2):154-63. PubMed ID: 12931087
[TBL] [Abstract][Full Text] [Related]
20. Advances in hematologic stem cell transplant: an update for oral health care providers.
Epstein JB; Raber-Durlacher JE; Wilkins A; Chavarria MG; Myint H
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Mar; 107(3):301-12. PubMed ID: 19217013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
